CLINICAL_TRIALS
trial_result
· 2011-01-21
Clinical Trial Update: Study to Evaluate Effectiveness of Aranesp® [Phase 4]
Summary
A Phase 4 post-marketing study evaluating the effectiveness of Aranesp (darbepoetin alfa) in patients with chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Kidney Disease | Phase 4 | Status: COMPLETED